These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7661007)

  • 1. Molecular characterization of IMP dehydrogenase in acquired resistance to mycophenolic acid.
    Snyder FF; Lightfoot T; Hodges SD
    Adv Exp Med Biol; 1994; 370():725-8. PubMed ID: 7661007
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased activity, amount, and altered kinetic properties of IMP dehydrogenase from mycophenolic acid-resistant neuroblastoma cells.
    Hodges SD; Fung E; McKay DJ; Renaux BS; Snyder FF
    J Biol Chem; 1989 Oct; 264(30):18137-41. PubMed ID: 2572589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene amplification and dual point mutations of mouse IMP dehydrogenase associated with cellular resistance to mycophenolic acid.
    Lightfoot T; Snyder FF
    Biochim Biophys Acta; 1994 Mar; 1217(2):156-62. PubMed ID: 7906545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagen-induced resistance to mycophenolic acid in hamster cells can be associated with increased inosine 5'-phosphate dehydrogenase activity.
    Huberman E; McKeown CK; Friedman J
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3151-4. PubMed ID: 6114490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and role of inosine-5'-monophosphate dehydrogenase in cell replication, malignant transformation, and differentiation.
    Huberman E; Glesne D; Collart F
    Adv Exp Med Biol; 1994; 370():741-6. PubMed ID: 7661012
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities.
    Ullman B
    J Biol Chem; 1983 Jan; 258(1):523-8. PubMed ID: 6129253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased inosinate dehydrogenase activity in mycophenolic acid resistant neuroblastoma cells.
    Hodges SD; Fung E; Lin CC; Snyder FF
    Adv Exp Med Biol; 1986; 195 Pt B():271-4. PubMed ID: 2876592
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid.
    Köhler GA; White TC; Agabian N
    J Bacteriol; 1997 Apr; 179(7):2331-8. PubMed ID: 9079920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human type I and II IMP dehydrogenases as drug targets.
    Natsumeda Y; Carr SF
    Ann N Y Acad Sci; 1993 Nov; 696():88-93. PubMed ID: 7906497
    [No Abstract]   [Full Text] [Related]  

  • 10. IMP-dehydrogenase (IMPDH), hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and phosphodiesterases (PDEs) expression during mycophenolic acid (MPA)-induced differentiation in human neuroblastoma cell lines.
    Quaratino CP; Messina E; Arduini A; Angelini G; Spoto G; Gizzi F; Ruffini I; Odorisio M; Giacomello A
    Adv Exp Med Biol; 1998; 431():439-41. PubMed ID: 9598106
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
    Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
    Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the IMP dehydrogenase gene in Chinese hamster cells resistant to mycophenolic acid.
    Collart FR; Huberman E
    Mol Cell Biol; 1987 Sep; 7(9):3328-31. PubMed ID: 2890098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
    Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
    J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic assessment of mycophenolic acid in a canine model.
    Langman LJ; Shapiro AM; Lakey JR; LeGatt DF; Kneteman NM; Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):934-6. PubMed ID: 8623469
    [No Abstract]   [Full Text] [Related]  

  • 15. Inosine 5'-monophosphate dehydrogenase.
    Pimkin M; Markham GD
    Adv Enzymol Relat Areas Mol Biol; 2009; 76():1-53. PubMed ID: 18990827
    [No Abstract]   [Full Text] [Related]  

  • 16. Cloning, characterization and validation of inosine 5'-monophosphate dehydrogenase of Babesia gibsoni as molecular drug target.
    Cao S; Aboge GO; Terkawi MA; Zhou M; Luo Y; Yu L; Li Y; Goo Y; Kamyingkird K; Masatani T; Suzuki H; Igarashi I; Nishikawa Y; Xuan X
    Parasitol Int; 2013 Apr; 62(2):87-94. PubMed ID: 23142571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and characterization of mycophenolic acid-resistant leukemia cells.
    Cohen MB
    Somat Cell Mol Genet; 1987 Nov; 13(6):627-33. PubMed ID: 2890214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-copy IMH3 allele is sufficient to confer resistance to mycophenolic acid in Candida albicans and to mediate transformation of clinical Candida species.
    Beckerman J; Chibana H; Turner J; Magee PT
    Infect Immun; 2001 Jan; 69(1):108-14. PubMed ID: 11119495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Mercaptopurine metabolism in two leukemic cell lines.
    Stet EH; De Abreu RA; Janssen YP; Bökkerink JP; Trijbels JM
    Adv Exp Med Biol; 1991; 309A():83-6. PubMed ID: 1686353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.